Regencell Bioscience Holdings Ltd
RGC- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001829667
No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Regencell Bioscience Holdings Ltd changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 3 | 2 | −1 |
| Shares | 14.0K | 7.01K | −6.96K (−49.8%) |
| Value | $316.0K | $230.0K | −$86.0K (−27.2%) |
New holders (2)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 6,816 | $224.0K | 0.00% |
| UBS Group AG | 192 | $6.00K | 0.00% |
Sold out (3)
Institutions that held Regencell Bioscience Holdings Ltd at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 10,200 | $231.0K |
| Tower Research Capital LLC (TRC) | 3,270 | $74.0K |
| Morgan Stanley | 503 | $11.0K |